June 2025
1. O'BYRNE AM, Grasso C, de Winde CM, Mikula AM, et al
   HLA-DR expressing lymph node fibroblasts maintain FoxP3+ regulatory T cells and are reduced in rheumatoid arthritis.
   Clin Exp Immunol. 2025 Jun 21:uxaf042. doi: 10.1093.
   

   >> Share

   
   May 2025
2. CHOWDHURY K, Kumar U, Chaudhuri J, Kumar P, et al
   Engaging PD-1 rescues regulatory T cell function and inhibits inflammatory T cells in rheumatoid arthritis.
   Clin Exp Immunol. 2025 May 28:uxaf035. doi: 10.1093.
   

   >> Share

   
   
3. DE JONG TA, Semmelink JF, Bolt JW, Grasso C, et al
   Senolytic treatment to rescue hallmarks of senescence in lymph node fibroblasts from patients with rheumatoid arthritis: Implications for premature aging and potential therapeutic intervention in early rheumatoid arthritis.
   Clin Exp Immunol. 2025 May 8:uxaf029. doi: 10.1093.
   

   >> Share

   
   January 2025
4. BORGE H, Ringstad IB, Aqrawi LA, Fromreide S, et al
   Increased expression of CXCL10 and CCL3 salivary gland chemokines in primary Sjogren's syndrome detected and systematically quantified using RNAscope(R)in situ hybridization.
   Clin Exp Immunol. 2025;219:uxae087.
   

   >> Share

   
   
5. FRESNEDA ALARCON M, Abdullah GA, Nolan A, Linford C, et al
   The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production, and NET release.
   Clin Exp Immunol. 2025;219:uxaf012.
   

   >> Share

   
   
6. NOACK M, Bailly M, Durix L, Pin JJ, et al
   Role of a new truncated CD74 isoform in increased IL-17 secretion from stromal-immune cell interactions.
   Clin Exp Immunol. 2025;219:uxaf047.
   

   >> Share

   
   
7. NAIGEON M, Bitoun S, Roulleaux Dugage M, de Oliveira C, et al
   Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines.
   Clin Exp Immunol. 2025;219:uxaf050.
   

   >> Share

   
   
8. MOSKOVITCH O, Anaki A, Caller T, Gilburd B, et al
   The Potential Of Autologous Patient-Derived Circulating Extracellular Vesicles To Improve Drug Delivery In Rheumatoid Arthritis.
   Clin Exp Immunol. 2025 Jan 4:uxae101. doi: 10.1093.
   

   >> Share

   
   November 2024
9. LI J, Wu Z, Wu Y, Hu X, et al
   IL-22, a vital cytokine in autoimmune diseases.
   Clin Exp Immunol. 2024;218:242-263.
   

   >> Share

   
   
10. RIMS C, Uchtenhagen H, Brooks K, Ng B, et al
    Antigen-specific T cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.
    Clin Exp Immunol. 2024 Nov 4:uxae102. doi: 10.1093.
    

    >> Share

    
    October 2024
11. JIA Y, Luan S, Huang S, Zhang W, et al
    Prevalence and clinical significance of anti-SSA antibody in the Chinese health screening population.
    Clin Exp Immunol. 2024;218:169-176.
    

    >> Share

    
    September 2024
12. MOUSTAKA K, Stergiopoulos A, Tenta R, Havaki S, et al
    Beta-adrenergic stimulation promotes an endoplasmic reticulum stress-dependent inflammatory program in salivary gland epithelial cells.
    Clin Exp Immunol. 2024;218:65-74.
    

    >> Share

    
    August 2024
13. CROSS AL, Wright HL, Choi J, Edwards SW, et al
    Circulating Neutrophil Extracellular Trap (NET)-forming neutrophils in rheumatoid arthritis exacerbation are majority dual endothelin-1/signal peptide receptor (DEspR)+ subtype.
    Clin Exp Immunol. 2024 Aug 7:uxae072. doi: 10.1093.
    

    >> Share

    
    July 2024
14. NOZAKI Y, Akiba H, Akazawa H, Yamazawa H, et al
    Inhibition of the TIM-1 and -3 Signaling Pathway Ameliorates Disease in a Murine Model of Rheumatoid Arthritis.
    Clin Exp Immunol. 2024 Jul 8:uxae056. doi: 10.1093.
    

    >> Share

    
    May 2024
15. KHANFAR E, Olasz K, Gal S, Gajdocsi E, et al
    Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice.
    Clin Exp Immunol. 2024;216:240-251.
    

    >> Share

    
    February 2024
16. IWAI T, Ohyama A, Osada A, Nishiyama T, et al
    Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
    Clin Exp Immunol. 2024;215:302-312.
    

    >> Share

    
    December 2023
17. FORNARO M, Girolamo F, Cacciapaglia F, Carabellese G, et al
    Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity.
    Clin Exp Immunol. 2023;214:94-102.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share